January 29, 2011 / 3:28 AM / 7 years ago

Jury awards plaintiff $482 mln in J&J stent battle

NEW YORK (Reuters) - A federal jury in Texas has rendered a $482 million verdict against Johnson & Johnson, finding its widely used Cypher stent infringes on the patent of an outside researcher, the company said on Friday.

A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado April 14, 2009. REUTERS/Rick Wilking/Files

Dr. Bruce Saffran filed the lawsuit, saying that his stent patent was valid and that the healthcare company infringed on it.

J&J said the company disagrees with the jury’s decision, and will fight it.

“We will ask the judge to overturn this verdict and if unsuccessful, we plan to appeal the verdict,” a J&J spokesperson said.

Saffran’s law firm, Dickstein Shapiro LLP, in a release, said the jury deliberated for two hours before returning its verdict.

The law firm said another federal jury in the same Marshall, Texas, courthouse three years ago rendered a $431.9 million verdict against Boston Scientific Corp, finding that its Taxus stent also infringed Saffran’s patent.

Reporting by Ransdell Pierson. Editing by Robert MacMillan

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below